CMS opens comment period on permanent Medicare drug-negotiation framework
CMS proposed long-term rules for negotiating and renegotiating prices for high-cost, single-source Medicare drugs beginning in 2029. Comments are due Aug. 17, 2026.
CMS proposed long-term rules for negotiating and renegotiating prices for high-cost, single-source Medicare drugs beginning in 2029. Comments are due Aug. 17, 2026.
